Home/Filings/4/0001209191-20-005778
4//SEC Filing

Buck Jill 4

Accession 0001209191-20-005778

CIK 0001107421other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 4:44 PM ET

Size

7.2 KB

Accession

0001209191-20-005778

Insider Transaction Report

Form 4
Period: 2020-01-29
Buck Jill
EVP, GM Gene Therapy
Transactions
  • Award

    Common Stock

    2020-01-29+53,700227,410 total
  • Award

    Employee Stock Option (right to buy)

    2020-01-29+82,60082,600 total
    Exercise: $4.21Exp: 2030-01-29Common Stock (82,600 underlying)
Footnotes (2)
  • [F1]17,900 shares shall vest on each of 12/31/2020, 12/31/2021 and 12/31/2022.
  • [F2]1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2019.

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeother

Related Parties

1
  • filerCIK 0001780426

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:44 PM ET
Size
7.2 KB